| PERIOD ENDING | 26-Sep-09 | 27-Sep-08 | 29-Sep-07 | | Total Revenue | 1,637,134 | 1,674,499 | 738,368 | | Cost of Revenue | 779,648 | 781,981 | 392,801 | | | Gross Profit | 857,486 | 892,518 | 345,567 | | | Operating Expenses | | Research Development | 94,328 | 81,421 | 44,484 | | Selling General and Administrative | 387,802 | 408,929 | 147,747 | | Non Recurring | 2,340,820 | 574,483 |
-
| | Others | 51,210 | 25,227 | 5,584 | | | | Total Operating Expenses | 2,874,160 | 1,090,060 |
-
| | | | Operating Income or Loss | (2,016,674) | (197,542) | 147,752 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,499) | 3,313 | 2,815 | | Earnings Before Interest And Taxes | (2,019,173) | (194,229) | 150,567 | | Interest Expense | 69,502 | 84,912 | 2,078 | | Income Before Tax | (2,088,675) | (279,141) | 148,489 | | Income Tax Expense | 87,562 | 106,476 | 53,911 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,176,237) | (385,617) | 94,578 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,176,237) | (385,617) | 94,578 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,176,237) | ($385,617) | $94,578 |
|
1.48% Nasdaq 
Income Statement
